​Zimmer Biomet—GPS III and Plasmax Kits: Manufacturer Reminds Customers to Use Products in Accordance with 510(k) Indications for Use

September 5, 2018 | Risk Management News

Preview

ECRI Institute's complete weekly summary of medical device hazard and recall information is available in ECRI Institute's Health Device Alerts. For more information contact us at clientservices@ecri.org.

In an August 23, 2018, Urgent Medical Device Correction letter submitted by ECRI Institute member hospitals, Zimmer Biomet states that certain components of the above products may be used to create an output called "lnterleukin-1 receptor agonist protein" (IRAP) for injection, which is an off-label use of these products. In addition to the term IRAP, this output is sometimes referred to as "autologous protein solution" (APS) or "Interleukin receptor agonist" (ILRA). Zimmer Biomet also states that the above products...

Access Full Content

Contact us today at 610.825.6000.

Related Tags